Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,911.74
+124.00
(
+3.17%
)
Dow 30
+2.73%
QQQ
+3.56%
VIX
27.23
-1.82
(
-6.27%
)
Tscan Therapeutics Inc
NASDAQ:TCRX
3.09
+0.07
(
+2.32%
)
Products
TScan Therapeutics Announces FDA Clearance Of Investigational New Drug Application For TSC-101
Published: 05/31/2022 12:00 GMT
TCRX
Tscan Therapeutics Inc (
TCRX
)
- Tscan Therapeutics Announces FDA Clearance of Investigational New Drug Application for Tsc-101 for the Treatment of Hematologic Malignancies.